DALDA (BCH-150)

Request For Quotation
DALDA (BCH-150) Suppliers list
Company Name: Shanghai Hanhong Scientific Co.,Ltd.  
Tel: 021-54306202 13764082696
Email: info@hanhongsci.com
Company Name: Chemsky (shanghai) International Co.,Ltd  
Tel: 021-50135380
Email: shchemsky@sina.com
Company Name: Nanjing Leon Biological Technology Co., Ltd.  
Tel: 025-84523390 -127; 17705183659
Email: sales@njleonbiotech.com
Company Name: Nanjing Peptide Biotech Ltd.  
Tel: 025-58361106-805 15951641583
Email: zhao.xu@njpeptide.com
Company Name: Chengdu Youngshe Chemical Co., Ltd.  
Tel: +86-17380623303
Email: Caroline@youngshechem.com

DALDA (BCH-150) manufacturers

  • DALDA
  • DALDA pictures
  • $1820.00
  • 2026-05-11
  • CAS:118476-85-0
  • Purity:
  • Supply Ability: 10g
DALDA (BCH-150) Basic information
Product Name:DALDA (BCH-150)
Synonyms:tyrosyl-arginyl-phenylalanyl-lysinamide;(D-Arg2,Lys4)-Dermorphin (1-4) amide H-Tyr-D-Arg-Phe-Lys-NH2;(D-arg2,lys4) dermorphin fragment*1-4 amide;DALDA (BCH-150) >96% (D-ARG2,LYS4)DERMOR PH;DALDA (BCH-150);L-Lysinamide, L-tyrosyl-D-arginyl-L-phenylalanyl-;(D-Arg?,Lys?)-Dermorphin (1-4) amide
CAS:118476-85-0
MF:C30H45N9O5
MW:611.74
EINECS:
Product Categories:
Mol File:118476-85-0.mol
DALDA (BCH-150) Structure
DALDA (BCH-150) Chemical Properties
density 1.36±0.1 g/cm3(Predicted)
storage temp. −20°C
solubility Methanol (Sligthly), Water (Slightly)
pka9.96±0.15(Predicted)
form solid
color white
Stability:Hygroscopic
Safety Information
Hazard Codes C
Risk Statements 20-35-52/53
Safety Statements 26-36/37/39-45-61-28-27-9
RIDADR UN 1759 8/PG 2
WGK Germany 3
MSDS Information
DALDA (BCH-150) Usage And Synthesis
Uses(D-Arg2,Lys4)-Dermorphin (1-4) Amide H-Tyr-D-Arg-Phe-Lys-NH2 uses of collagen binding domains to deliver products to skin.
in vivo

DALDA (0-7 nmol/rat; i.t.; once) shows antinociceptive and respiratory effects in rats[1].
DALDA (0.1 and 1.0 μg/side; ICV; once) results in biphasic effects, with an initial suppression, an intermediate marked inhibition, followed by activation for horizontal movement, rearing and stereotypy times in rats[2].

Animal Model:Male Sprague-Dawley rats (300–350 g)[1]
Dosage:0.24, 0.7 and 7 nmol/rat
Administration:Intrathecal injection, once
Result:Showed antinociceptive effects with an ED50 of 237 pmol/rat in the rat tail-flick test. Inhibited the uptake of NE in spinal cord synaptosomes in a dose-dependent manner. Had no effect on 5-HT uptake. Produced depression in minute ventilation.
Animal Model:Male Long-Evans rats, weighing 200-225 g[2]
Dosage:0, 0.1 and 1.0 μg/side, 0.5 μL
Administration:Lateral cerebral ventricle injection, once
Result:Elicited a significant biphasic effect with an initial suppression, an intermediate marked inhibition, followed by significant activation for horizontal movement time, rearing time, and stereotypy time.
IC 50μ Opioid Receptor/MOR: 1.69 nM (Ki); κ Opioid Receptor/KOR: 4230 nM (Ki); δ Opioid Receptor/DOR: 19200 nM (Ki)
DALDA (BCH-150) Preparation Products And Raw materials
Tag:DALDA (BCH-150)(118476-85-0) Related Product Information
JDTic (2HCl) Naloxegol Oxalate Naloxone hydrochloride ENDOMORPHIN-1 Bisacodyl DAGO